AVR anteris technologies global corp.

6.09%

$6.27

E, I agree. there is the potential for A LOT OF NEWS that could...

First 16 Last

Share
Profile

Follow
disaster

252 Posts.

45

21/06/22

21:23

Post #: 62123345
Share

Originally posted by Eire2011: ↑

A lot of investors are forgetting that the primary end point for the FDA EFS study is only 30 days!

So we know approval is imminent, but let’s say it takes another 30 days for the green light (but could be any day now), let’s say recruitment takes 30 days, and results take 1 month after the 30 days. That’s another 4 months and just in time to be released as “Breakthrough” trial results at PCR London Valves. The biggest European structural heart conference.

That’s the company plan although it is reliant on FDA timelines. But very doable IMO.

Add onto that additional results from the Georgia patients and there is no shortage of newsflow. But the FDA news will be the biggest.

Plus, one must not forget that our results are very impressive and the Laminar flow is unique in the industry. Very good grounds to meet all required criteria for DurAVR to be granted Breakthrough Device Status. More potential news to come.

Things are certainly going to get very interesting and exciting from here.

DYOR and Not advice.

Expand

E, I agree. there is the potential for A LOT OF NEWS that could come in the next 6 - 12 months ...and this news could be linked to commercial sales...........
after 10 years in this game, it might be our time in the sun.

AVR Price at posting: $23.00 Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

'Not possible' to port renewable gas: ACCC takes AGN to court

First 16 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $6.27		Change 0.360(6.09%)		Mkt cap ! $97.17M

Open	High	Low	Value	Volume
$5.93	$6.30	$5.91	$107.9K	17.39K

Buyers (Bids)

No.	Vol.	Price($)
1	3500	$6.12

Sellers (Offers)

Price($)	Vol.	No.
$6.27	200	1

View Market Depth

No.	Vol.	Price($)
1	3500	6.120
1	2000	6.100
1	1000	6.000
1	1250	5.950
1	857	5.830

Price($)	Vol.	No.
6.270	200	1
6.300	463	1
6.400	130	1
6.500	255	1
6.550	1092	1

Last trade - 15.42pm 27/06/2025 (20 minute delay)

AVR (ASX) Chart

E, I agree. there is the potential for A LOT OF NEWS that could...

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

E, I agree. there is the potential for A LOT OF NEWS that could...

Top Stories

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Boss extends June win streak with boosted Alta Mesa extraction rates

'Not possible' to port renewable gas: ACCC takes AGN to court

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News